10-97677987-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021732.3(AVPI1):c.326G>A(p.Ser109Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,614,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021732.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AVPI1 | NM_021732.3 | c.326G>A | p.Ser109Asn | missense_variant | 3/3 | ENST00000370626.4 | |
AVPI1 | XM_017016494.2 | c.326G>A | p.Ser109Asn | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AVPI1 | ENST00000370626.4 | c.326G>A | p.Ser109Asn | missense_variant | 3/3 | 1 | NM_021732.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000560 AC: 14AN: 249822Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135142
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461876Hom.: 0 Cov.: 30 AF XY: 0.0000261 AC XY: 19AN XY: 727244
GnomAD4 genome AF: 0.000184 AC: 28AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | The c.326G>A (p.S109N) alteration is located in exon 3 (coding exon 2) of the AVPI1 gene. This alteration results from a G to A substitution at nucleotide position 326, causing the serine (S) at amino acid position 109 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at